Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysis.

Q1 Medicine CNS Oncology Pub Date : 2021-09-01 Epub Date: 2021-09-21 DOI:10.2217/cns-2021-0009
Jennifer H Kang, Christa B Swisher, Evan D Buckley, James E Herndon, Eric S Lipp, John P Kirkpatrick, Annick Desjardins, Henry S Friedman, Margaret O Johnson, Dina M Randazzo, David M Ashley, Katherine B Peters
{"title":"Primary brain tumor patients admitted to a US intensive care unit: a descriptive analysis.","authors":"Jennifer H Kang,&nbsp;Christa B Swisher,&nbsp;Evan D Buckley,&nbsp;James E Herndon,&nbsp;Eric S Lipp,&nbsp;John P Kirkpatrick,&nbsp;Annick Desjardins,&nbsp;Henry S Friedman,&nbsp;Margaret O Johnson,&nbsp;Dina M Randazzo,&nbsp;David M Ashley,&nbsp;Katherine B Peters","doi":"10.2217/cns-2021-0009","DOIUrl":null,"url":null,"abstract":"<p><p><b>Purpose:</b> To describe our population of primary brain tumor (PBT) patients, a subgroup of cancer patients whose intensive care unit (ICU) outcomes are understudied. <b>Methods:</b> Retrospective analysis of PBT patients admitted to an ICU between 2013 to 2018 for an unplanned need. Using descriptive analyses, we characterized our population and their outcomes. <b>Results:</b> Fifty-nine PBT patients were analyzed. ICU mortality was 19% (11/59). The most common indication for admission was seizures (n = 16, 27%). <b>Conclusion:</b> Our ICU mortality of PBT patients was comparable to other solid tumor patients and the general ICU population and better than patients with hematological malignancies. Further study of a larger population would inform guidelines for triaging PBT patients who would most benefit from ICU-level care.</p>","PeriodicalId":10469,"journal":{"name":"CNS Oncology","volume":"10 3","pages":"CNS77"},"PeriodicalIF":0.0000,"publicationDate":"2021-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/68/64/cns-10-77.PMC8461751.pdf","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CNS Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/cns-2021-0009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2021/9/21 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2

Abstract

Purpose: To describe our population of primary brain tumor (PBT) patients, a subgroup of cancer patients whose intensive care unit (ICU) outcomes are understudied. Methods: Retrospective analysis of PBT patients admitted to an ICU between 2013 to 2018 for an unplanned need. Using descriptive analyses, we characterized our population and their outcomes. Results: Fifty-nine PBT patients were analyzed. ICU mortality was 19% (11/59). The most common indication for admission was seizures (n = 16, 27%). Conclusion: Our ICU mortality of PBT patients was comparable to other solid tumor patients and the general ICU population and better than patients with hematological malignancies. Further study of a larger population would inform guidelines for triaging PBT patients who would most benefit from ICU-level care.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
美国重症监护病房收治的原发性脑肿瘤患者:描述性分析。
目的:描述我们的原发性脑肿瘤(PBT)患者群体,这是一组重症监护病房(ICU)预后研究不足的癌症患者。方法:回顾性分析2013年至2018年因计划外需求入住ICU的PBT患者。使用描述性分析,我们描述了我们的人口和他们的结果。结果:对59例PBT患者进行分析。ICU死亡率为19%(11/59)。最常见的入院指征是癫痫发作(n = 16.27%)。结论:PBT患者的ICU死亡率与其他实体瘤患者和普通ICU人群相当,优于血液系统恶性肿瘤患者。对更大的人群进行进一步的研究,将为鉴别哪些PBT患者最受益于icu级别的护理提供指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CNS Oncology
CNS Oncology Medicine-Neurology (clinical)
CiteScore
3.80
自引率
0.00%
发文量
12
审稿时长
13 weeks
期刊最新文献
Novel insights toward diagnosis and treatment of glioneuronal and neuronal tumors in young adults. Autologous stem cell transplantation in adults with atypical teratoid rhabdoid tumor: a case report and review. Neurofilament light chain in serum of cancer patients with acute neurological complications. Development of brain metastases in non-small-cell lung cancer: high-risk features. The challenges and clinical landscape of glioblastoma immunotherapy.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1